glp-1 and gastric bypass Metabolic Bariatric Surgery vs. Receptor Agonists for Obesity Management GLP-1 vs Bariatric Surgery Study:

Visceral fat or metabolic resistance: Tesamorelin or MOTS-C

More serious but less common adverse effects from these medications include: Blockage in the intestine or bile duct Gallstones Gastroparesis (delayed stomach emptying) Pancreatitis (inflammation of the pancreas) These medications also carry a black box warning that they may increase the risk for thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)

Furthermore, this patient subgroup reported increased adverse events related to weight loss (ROR = 10.85, 95% CI 9.1212.91) and metabolic disturbances

[PMC free article] [PubMed] [Google Scholar] 241.Noble J.M., Weimer L.H